top of page

Cardiovascular

Health

CardioMetabolic 

Health

Lung Health

Bone Health

All-in-one AI-CVD

497e6f54-782b-4e077a-3a7144e4f3e4.png

AutoFracture

(coming soon)

upscaled_5x.png
upscaled_5x.png
upscaled_5x.png
upscaled_5x.png
upscaled_5x.png
upscaled_5x.png
upscaled_5x.png
upscaled_5x.png
upscaled_5x.png
0bdba309-a76a-4215-b207-90a7932bb681.png
iScreen Shoter - 20260520111737117 1.png
Frame 1000004271.png
iScreen Shoter - 20260520105243724 1.png
iScreen Shoter - 20260520105243724 1.png
iScreen Shoter - 20260520100645073 1.png

1 Non-Contrast Scan              10+ Actionable Reports

Vision 2030: Preventive Imaging Agentic AI

  • Jul 15
  • 1 min read

Thursday, July 9, 2026 | 2:00-3:00 PM PST LDCT Mega Trial



Vision 2030 presents HeartLung.AI’s long-term vision for transforming medical imaging into a comprehensive, AI-powered preventive healthcare ecosystem. Rather than generating a diagnostic report alone, the platform is designed to convert a single medical image into a personalized prevention strategy that follows patients throughout their lives.

The proposed Preventive Imaging Agentic AI framework integrates multiple intelligent agents into a unified workflow—from image acquisition and automated disease detection to quantitative imaging biomarkers, clinical reasoning, physician oversight, patient communication, and continuous learning. Each stage is designed to improve accuracy, enhance safety, and support evidence-based preventive care while keeping physicians at the center of every clinical decision.

By combining advanced imaging AI with electronic health records, wearable data, clinical guidelines, and adaptive learning, the platform aims to detect diseases before symptoms develop, deliver personalized prevention plans, and make preventive healthcare scalable for millions of people.

This presentation outlines HeartLung.AI’s roadmap toward an intelligent healthcare ecosystem where one scan can identify multiple diseases, guide personalized interventions, and continuously improve through real-world clinical outcomes.

Download the complete presentation below to explore the Vision 2030 architecture, the eight-step Agentic AI workflow, and the future of AI-driven preventive medicine.




Comments


Ready to Unlock the Value in Your CT Scans?

Join leading healthcare providers using AI-CVD to save lives and increase revenue, and lead the future of preventive cardiology.

  • Twitter
  • LinkedIn
  • Facebook
  • Instagram
  • Youtube

2450 Holcombe Blvd
TMC Innovations
Houston, TX 77021

aicvd patent_edited_edited.jpg
ISO LOGO_edited.png

©2026 HeartLung Corporation. All Rights Reserved. US Patent Nos US9119590*, US10695022, US11610686, US18167691, US20240115224, and Patents Pending. AI-CVD, AI-CAC, AutoBMD, AutoCAC, AutoChamber and other trademarks shown on this website are protected under intellectual property rights of HeartLung Corporation in the United States.

bottom of page